miRNome of inflammatory breast cancer

BMC Research Notes

Table 1 Clinico-pathological characteristics of breast cancer samples

	Breast carcinomas		p-value^a,b
	nonIBC	IBC
Characteristics (nb,%)	(n = 17)	(n = 13)
Age
Mean ± SD	57.4 ± 12.4	54.4 ± 13.4	0.27^a
≤50	5 (29%)	5 (38%)	0.71^b
>50	12 (71%)	8 (62%)	0.71^b
Stage
I	4 (24%)	0 (0%)	<0.001^b
II	1 (6%)	0 (0%)
IIA	8 (47%)	0 (0%)
IIB	1 (6%)	1 (8%)
III	0 (0%)	1 (8%)
IIIA	2 (12%)	0 (0%)
IIIB	0 (0%)	9 (69%)
IIIC	1 (6%)	1 (8%)
IV	0 (0%)	1 (8%)
Distant metastates
Yes	0 (0%)	2 (15%)	0.18^b
No	17 (100%)	11 (85%)
Estrogen receptor status
Positive	12 (71%)	5 (38%)	0.14^b
Negative	5 (29%)	8 (62%)	0.14^b
Progesterone receptor status
Positive	9 (53%)	2 (15%)	0.06^b
Negative	8 (47%)	11 (85%)	0.06^b
HER2 status
Positive	4 (24%)	2 (15%)	0.67^b
Negative	13 (76%)	11 (85%)	0.67^b
Molecular subtypes
HR^-HER2^-	3 (18%)	7 (54%)	0.19^b
HR^-HER2⁺	1 (6%)	1 (8%)
HR⁺HER2^-	10 (59%)	4 (31%)
HR⁺HER2⁺	3 (18%)	1 (8%)

ISSN: 1756-0500